title: "Dualities of interest": the inter-organizational relationships between disease-specific nonprofits and the pharmaceutical industry.
abstract: Health care and biomedical research environments in the United States are largely characterized by strategic relational practices conducted beyond the public gaze. The very nature of health care has been widely reconceptualized from a response to physical/biological imperatives regulated by health promotion and the epidemiological distribution of diseases to profit/market imperatives regulated by "product/brand" promotion and market dynamics. At critical decision points throughout the system, we find the multinational pharmaceutical industry wielding the influence that its wealth and power have bought. This study contributes to the growing body of work that seeks to illuminate the relationships between the pharmaceutical industry and the various entities that constitute the U.S. health and research systems. Through the use of case studies, it examines the relationships between the multinational pharmaceutical industry and the large disease-specific public and professional nonprofit organizations. It explores several questions, including: Is the concept of what constitutes a conflict of interest being purposefully manipulated? Is the public benevolence afforded to nonprofits extended to their corporate partners in ways that preclude critical oversight of relational dynamics? And are public donations, solicited by and given in good faith to these organizations, inevitably serving the economic interests and profits of donor pharmaceutical companies?
authors.affiliation: joanpaluzzi@gmail.com
authors.forename: Joan E
authors.initials: JE
authors.lastname: Paluzzi
mesh_terms: D035843:Biomedical Research / Q000458:organization & administration*; D016265:Conflict of Interest; D003920:Diabetes Mellitus / Q000188:drug therapy; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D007373:Interinstitutional Relations; D009939:Organizations, Nonprofit / Q000458:organization & administration*; D010024:Osteoporosis / Q000188:drug therapy; D012148:Restless Legs Syndrome / Q000188:drug therapy